French cancer centre Institut Curie has introduced Ibex Medical’s AI tools to support pathologists diagnosing cancer.
According to Israel-based health technology company Ibex, pathologists at Institut Curie will now use its AI tools in their routine clinical practice to enhance accuracy and improve patient outcomes.
The new AI tools will be initially used in the diagnosis of prostate cancer, with plans to expand to other applications in future, said the Israeli health technology company.
Ibex Medical Analytics CEO Joseph Mossel said: “We are honoured to see our AI platform deployed in routine practice at such a prestigious institution as Institut Curie.
“As one of the world’s leading medical and research centres, Institut Curie remains at the forefront of transforming cancer care.
“This rollout underscores our commitment to making computational pathology a global reality and highlights the transformative potential of AI to reshape the future of cancer care.”
Established in 1909 by Marie Curie, Institut Curie has more than 3,800 researchers, doctors and caregivers working at three sites, in Paris, Saint-Cloud and Orsay.
The organisation, which is authorised to receive donations and legacies, is supporting discoveries, and improving treatments and the quality of life of patients.
Institut Curie is the first academic laboratory to use Ibex’s recently released AI solution through their Sectra Digital Pathology Solution, to ensure seamless diagnostic workflows.
The institute’s digital pathology adoption would provide an integrated workflow for pathologists to access the AI findings when reviewing cases.
The deployment is the latest update in the ongoing collaboration between the two organisations, which already yielded advancements in AI-driven cancer diagnostics.
University Paris-Sciences et Lettres professor, and Institut Curie pathology department head professor Anne Vincent-Salomon said: “We’re excited to now use Ibex’s AI technology in routine practice, further building upon our impressive research partnership.
“It’s a team success between the Pathology team, the IT department, the data protection officer and the Information systems security managers.
“We realise the vital role that accurate diagnostics play in selecting optimal treatment paths, and we’re committed to providing our pathologists with the top-tier technology and tools to ensure every patient receives the highest quality care.”
Institut Curie pathology department head and University Versailles Saint Quentin professor Yves Allory said: “The implementation of this tool in our department will allow our teams to save time, make our results more reliable, target areas of interest and improve the accuracy of our diagnoses.”
